Trial To Assess The Safety And Tolerability Of Lucinactant For Inhalation In Preterm Neonates 26 to 28 Weeks PMA
Clinical trial NCT02528318 · TERMINATED
Trial details
- NCT number
- NCT02528318
- Sponsor
- Windtree Therapeutics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2017-05-31
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.